A Study of Glucosylceramide Synthase and Glycolytic Pathway Enzymes in Patients with Hypereosinophilia
<p>Glucosylceramide synthase is the rate limiting enzyme in ceramide glycosylation and shifts the balance between ceramide and glycosphingolipids towards proliferation and survival of cancer cells. Increased glucose availability and glycolytic metabolism is preferentially used by cancer cells...
Kaydedildi:
Asıl Yazarlar: | Lisa Redmond (Yazar), Paul Kennedy (Yazar), Colm Buckley (Yazar), Philip T Murphy (Yazar) |
---|---|
Materyal Türü: | Kitap |
Baskı/Yayın Bilgisi: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2017-03-31.
|
Konular: | |
Online Erişim: | Connect to this object online. |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Benzer Materyaller
-
Quantification of glucosylceramide in plasma of Gaucher disease patients
Yazar:: Maria Viviane Gomes Muller, ve diğerleri
Baskı/Yayın Bilgisi: (2010) -
Glycolytic enzyme inhibitory and antiglycation potential of rutin
Yazar:: Shagun Dubey, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
Successful use of antihistamines in severe hypereosinophilia
Yazar:: Stefano Vallero, ve diğerleri
Baskı/Yayın Bilgisi: (2012) -
Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
Yazar:: Shiyu Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2023) -
Lymphoid aggregates in bone marrow biopsies in patients with hypereosinophilia
Yazar:: Sharma Seema, ve diğerleri
Baskı/Yayın Bilgisi: (2008)